Eupraxia Pharmaceuticals Inc opened trading today at $3.73 and closed at $4.04. It traded at a low of $3.73 to a high of $4.09.

Share prices advanced 9.19% from the previous day's close of $3.70.

During the day across North America, the TSX Composite closed tsx_percentage_change% at 21807.37, the S&P 500 closed sp_500_percentage_change% at 4967.23, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37986.40 and the Nasdaq Composite closed nasdaq_percentage_change% at 15282.01.

Eupraxia Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker EPRX.

Trading volume was 72,753 on 136 total trades. On average, Eupraxia Pharmaceuticals Inc has traded 70,166 shares over 5 days and 57,395 year-to-date.

The TSX market on the whole today saw 3,754 price advancers against 1,430 declines and 130 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $9.10 (July 05,2023) and low as $3.44 (April 18,2024). Moreover, in the last 52 weeks, Eupraxia Pharmaceuticals Inc's shares have reduced -30.10 percent, while they have shrunken -24.77% since the start of 2024.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $131.80 million on a float of 35,623 shares outstanding. Its annual EPS is $-1.17.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Currently, Eupraxia Pharmaceuticals Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..